189 related articles for article (PubMed ID: 34726247)
41. Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure.
Donnarumma E; Bhushan S; Bradley JM; Otsuka H; Donnelly EL; Lefer DJ; Islam KN
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473036
[TBL] [Abstract][Full Text] [Related]
42. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
Sivaraman V; Yellon DM
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
[TBL] [Abstract][Full Text] [Related]
43. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.
Wu Y; Liu H; Wang X
Life Sci; 2021 Jan; 264():118628. PubMed ID: 33131670
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
45. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
Sanada S; Komuro I; Kitakaze M
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
[TBL] [Abstract][Full Text] [Related]
46. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
47. Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential.
Lavu M; Bhushan S; Lefer DJ
Clin Sci (Lond); 2011 Mar; 120(6):219-29. PubMed ID: 21126235
[TBL] [Abstract][Full Text] [Related]
48. Sevoflurane post-conditioning reduces rat myocardial ischemia reperfusion injury through an increase in NOS and a decrease in phopshorylated NHE1 levels.
Cao J; Xie H; Sun Y; Zhu J; Ying M; Qiao S; Shao Q; Wu H; Wang C
Int J Mol Med; 2015 Dec; 36(6):1529-37. PubMed ID: 26459736
[TBL] [Abstract][Full Text] [Related]
49. Hydrogen sulfide releasing hydrogel for alleviating cardiac inflammation and protecting against myocardial ischemia-reperfusion injury.
Zhang Q; Wang L; Yin Y; Shen J; Xie J; Yuan J
J Mater Chem B; 2022 Jul; 10(28):5344-5351. PubMed ID: 35792619
[TBL] [Abstract][Full Text] [Related]
50. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
51. Cardioprotection of CAPE-oNO
Li D; Wang X; Huang Q; Li S; Zhou Y; Li Z
Redox Biol; 2018 May; 15():62-73. PubMed ID: 29220696
[TBL] [Abstract][Full Text] [Related]
52. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.
Herzog C; Schmitz M; Levkau B; Herrgott I; Mersmann J; Larmann J; Johanning K; Winterhalter M; Chun J; Müller FU; Echtermeyer F; Hildebrand R; Theilmeier G
Mediators Inflamm; 2010; 2010():425191. PubMed ID: 21274265
[TBL] [Abstract][Full Text] [Related]
53. Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury.
Luo Y; Liu LM; Xie L; Zhao HL; Lu YK; Wu BQ; Wu ZY; Zhang ZL; Hao YL; Ou WH; Liu RS; Xu WM; Chen XH
Exp Cell Res; 2021 Jan; 398(2):112389. PubMed ID: 33221316
[TBL] [Abstract][Full Text] [Related]
54. Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts.
Chen J; Gao J; Sun W; Li L; Wang Y; Bai S; Li X; Wang R; Wu L; Li H; Xu C
Int J Cardiol; 2016 Oct; 220():681-92. PubMed ID: 27393850
[TBL] [Abstract][Full Text] [Related]
55. Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.
Wu D; Wang J; Li H; Xue M; Ji A; Li Y
Oxid Med Cell Longev; 2015; 2015():186908. PubMed ID: 26064416
[TBL] [Abstract][Full Text] [Related]
56. Design, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors.
Zhao Y; Yang C; Organ C; Li Z; Bhushan S; Otsuka H; Pacheco A; Kang J; Aguilar HC; Lefer DJ; Xian M
J Med Chem; 2015 Sep; 58(18):7501-11. PubMed ID: 26317692
[TBL] [Abstract][Full Text] [Related]
57. HIF‑1α in myocardial ischemia‑reperfusion injury (Review).
Zheng J; Chen P; Zhong J; Cheng Y; Chen H; He Y; Chen C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760122
[TBL] [Abstract][Full Text] [Related]
58. Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism.
Snijder PM; de Boer RA; Bos EM; van den Born JC; Ruifrok WP; Vreeswijk-Baudoin I; van Dijk MC; Hillebrands JL; Leuvenink HG; van Goor H
PLoS One; 2013; 8(5):e63291. PubMed ID: 23675473
[TBL] [Abstract][Full Text] [Related]
59. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.
Li J; Loukili N; Rosenblatt-Velin N; Pacher P; Feihl F; Waeber B; Liaudet L
PLoS One; 2013; 8(7):e70331. PubMed ID: 23875026
[TBL] [Abstract][Full Text] [Related]
60. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection.
Osipov RM; Robich MP; Feng J; Liu Y; Clements RT; Glazer HP; Sodha NR; Szabo C; Bianchi C; Sellke FW
J Cardiovasc Pharmacol; 2009 Oct; 54(4):287-97. PubMed ID: 19620880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
